1. Home
  2. CNK vs RCUS Comparison

CNK vs RCUS Comparison

Compare CNK & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cinemark Holdings Inc Cinemark Holdings Inc.

CNK

Cinemark Holdings Inc Cinemark Holdings Inc.

HOLD

Current Price

$37.04

Market Cap

4.3B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$30.25

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNK
RCUS
Founded
1984
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.6B
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
CNK
RCUS
Price
$37.04
$30.25
Analyst Decision
Buy
Buy
Analyst Count
10
10
Target Price
$33.70
$31.90
AVG Volume (30 Days)
2.5M
1.2M
Earning Date
05-01-2026
05-05-2026
Dividend Yield
1.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,115,000,000.00
$247,000,000.00
Revenue This Year
$11.01
N/A
Revenue Next Year
$3.70
$45.62
P/E Ratio
N/A
N/A
Revenue Growth
2.15
N/A
52 Week Low
$21.60
$10.07
52 Week High
$38.98
$31.74

Technical Indicators

Market Signals
Indicator
CNK
RCUS
Relative Strength Index (RSI) 61.01 58.95
Support Level $36.28 $25.94
Resistance Level $38.98 $31.41
Average True Range (ATR) 0.97 1.14
MACD -0.24 0.13
Stochastic Oscillator 36.10 70.80

Price Performance

Historical Comparison
CNK
RCUS

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: